You just read:

myTomorrows Announces an Agreement With Spectrum for an Early Access Program for Pralatrexate Injection for Patients With Peripheral T-Cell Lymphoma (PTCL)

News provided by

myTomorrows

19 Oct, 2015, 06:10 BST